Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Intervertebral disc degeneration; Spondylosis
- Focus Therapeutic Use
- 13 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov.
- 28 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov.